UnitedHealth Group close to buying Helios for about $1.6 billion

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Endo Announces Peyronie’s Disease Presentation at...

Endo, a wholly-owned subsidiary of Mallinckrodt plc, announced today...

Leadership at NHS Hospitals in Leeds...

A watchdog has gone on to say that the...

Developing Dr. CaBot, A Medical Education...

Harvard Medical School researchers are developing Dr. CaBot as...

UK & U.S. Regulators Partner for...

The medicines regulator of the UK has announced plans...
Health Insurer UnitedHealth Group Inc (UNH.N) is nearing a deal to buy Helios for more than $1.6 billion, according to a source familiar with the matter.
The takeover of Helios, which is owned by Kelso & Company and Stone Point Capital LLC, could be announced as early as this week, Bloomberg reported earlier on Wednesday, citing people with knowledge of the matter.
No decision has been made and the talks may fall apart, Bloomberg said.
Based in Memphis, Tennessee, Helios provides workers' compensation and pharmacy benefit management to some of the largest U.S. insurers and third-party administrators. It manages more than 7 million prescriptions annually.
A takeover of Helios would follow UnitedHealth's recent $12.8 billion acquisition of Catamaran Corp in an attempt to boost its pharmacy benefit business.
UnitedHealth declined to comment and Helios could not be reached immediately for comment outside regular business hours.

Latest stories

Related stories

Developing Dr. CaBot, A Medical Education Tool That Reasons

Harvard Medical School researchers are developing Dr. CaBot as...

UK & U.S. Regulators Partner for Medtech Regulatory Reforms

The medicines regulator of the UK has announced plans...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »